In GEP-NEN patients, the PD-L1-negative region is dominant in tumor centers, while PD-L1 is mainly expressed in the tumors and immune cells at the frontier of tumor invasion, and the density of CD8 and PD-1 immune cell infiltration is higher in PD-L1-positive tumor regions [52]. This evidence concerns the gene PDCD1 and neoplasm.